SYN004 / Synermore  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SYN004 / Synermore
NCT02563106 / 2015-002346-32: A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Completed
2
413
Canada, US, Europe, RoW
SYN-004, Placebo
Synthetic Biologics Inc.
Clostridium Difficile, Clostridium Infections
11/16
11/16
NCT02419001: A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy

Completed
1b/2a
11
Canada, US
Period 1 - Treatment Sequence AB, Period 1 - Treatment Sequence AC, Period 2 - Treatment Sequence AB, ribaxamase, Period 2 - Treatment Sequence AC
Synthetic Biologics Inc.
Healthy Volunteers
09/15
10/15
NCT02473640: A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

Completed
1b/2a
15
Canada
SYN-004, Esomeprazole, Ceftriaxone
Synthetic Biologics Inc.
Healthy Volunteers With Ileostomy
04/16
04/16
NCT04692181: SYN-004 Safety and Tolerability in Allo-HCT Subjects

Recruiting
1b/2a
36
US
SYN-004, Ribaxamase or Placebo
Theriva Biologics, Inc., Washington University School of Medicine
121121000119106, Acute Graft-versus-host Reaction Following Bone Marrow Transplant (Disorder)
12/24
12/25

Download Options